SavedAdd your journal

Journals / Türk Fen ve Sağlık Dergisi / 2022 / Cilt: 3 - Sayı: 3

Investigation of Analgesic Effects of Venlafaxine, Atomoxetine and Trazodone Alone and in Combination in Acute Pain Models of the Rats

Münteha Zeynep KEMERLİ
Kemal YILDIRIM
Zıad JOHA
Ahmet Şevki TAŞKIRAN
İhsan BAĞCİVAN
Pages
254–265
Publication Date
2022-09-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: All in all, our data suggest these combinations may offer a beneficial treatment option for acute pain in future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Poorly controlled pain is linked to several other undesirable outcomes.
📊
Key Findings & Data:Our study aimed to examine the pain relief effectiveness of Venlafaxine, Atomoxetine and Trazodone at 3 different doses alone, and in combination with each other in an acute pain model.
💡
Conclusion & Impact:Conclusion: All in all, our data suggest these combinations may offer a beneficial treatment option for acute pain in future.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Acute Pain · Venlafaxine · Atomoxetine

Abstract

Purpose: Poorly controlled pain is linked to several other undesirable outcomes. These outcomes are upsetting to patients, their families, and society as a whole. Although opioids and non-steroidal anti-inflammatory drugs are the cornerstone of the nociceptive pain treatment, the use of these drugs is restricted due to their side effects. Therefore, it is essential to develop new treatment alternatives for pain. Our study aimed to examine the pain relief effectiveness of Venlafaxine, Atomoxetine and Trazodone at 3 different doses alone, and in combination with each other in an acute pain model. Material and Methods: The analgesic effectiveness of Venlafaxine, Atomoxetine, and Trazodone at three different doses alone and in combination in an acute pain model in rats was examined using the hot plate and tail flick methods. Results: Venlafaxine and Trazodone, Venlafaxine showed dose-dependent analgesic effect when compared to the control. When Venlafaxine at dose of 2 mg/kg were combined with Atomoxetine at doses of 1, 3 and 6 mg/kg, the analgesic effects were significantly increased compared to these drugs alone. When Venlafaxine at dose of 2 mg/kg were combined with trazodone at doses of 4, 12 and 24 mg/kg, the analgesic effects were significantly increased compared to these drugs alone. Conclusion: All in all, our data suggest these combinations may offer a beneficial treatment option for acute pain in future.

🔖

Cite This Article

KEMERLİ, M. Z., YILDIRIM, K., JOHA, Z., TAŞKIRAN, A. Ş., BAĞCİVAN, İ. (2022). Investigation of Analgesic Effects of Venlafaxine, Atomoxetine and Trazodone Alone and in Combination in Acute Pain Models of the Rats. Türk Fen ve Sağlık Dergisi, Cilt: 3 - Sayı: 3, 254–265. https://ajindex.com/articles/811466

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Barbaros, M.B., Can, Ö.D., Üçel, U.I., Yücel, N.T., DemirÖzkay, Ü., 2018. Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems. Mol. 2018, Vol. 23, Page 2072 23, 2072. https://doi.org/10.3390/MOLECULES23082072
  2. Bonnefont, J., Chapuy, E., Clottes, E., Alloui, A., Eschalier, A., 2005. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain 114, 482–490. https://doi.org/10.1016/J.PAIN.2005.01.019
  3. Cegielska-Perun, K., Bujalska-Zadrozny, M., Makulska-Nowak, H.E., 2012. Modification of morphine analgesia by venlafaxine in diabetic neuropathic pain model. Pharmacol. Reports 64, 1267–1275. https://doi.org/10.1016/S1734-1140(12)70923-4
  4. Chen, J. (Steven), Kandle, P.F., Murray, I., Fitzgerald, L.A., Sehdev, J.S., 2021.
  5. Physiology, Pain. StatPearls. Cortes-Altamirano, J.L., Olmos-Hernandez, A., Jaime, H.B., Carrillo-Mora, P., Bandala, C., Reyes-Long, S., Alfaro-Rodríguez, A., 2018. Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System. Curr. Neuropharmacol. 16. https://doi.org/10.2174/1570159X15666170911121027
  6. Demirkazik, A., Ozdemir, E., Arslan, G., Taskiran, A.S., Pelit, A., 2019. The effects of extremely low-frequency pulsed electromagnetic fields on analgesia in the nitric oxide pathway. Nitric Oxide - Biol. Chem. 92, 49–54. https://doi.org/10.1016/j.niox.2019.08.003 Fernández-Dueñas, V., Poveda, R., Fernández, A., Sánchez, S., Planas, E., Ciruela, F., 2011. Fentanyl–trazodone–paracetamol triple drug combination: Multimodal analgesia in a mouse model of visceral pain. Pharmacol. Biochem. Behav. 98, 331–336. https://doi.org/10.1016/J.PBB.2011.01.023
  7. Florkowski, A., Gruszczyński, W., Gałecki, P., Zboralski, K., Kołodziejska, I., Mikołajczyk, I., 2005. [Trazodone and venlafaxine in treatment of depressive disorders]. Pol. Merkur. Lekarski 18, 556–559.
  8. Fornasari, D., 2017. Pharmacotherapy for Neuropathic Pain: A Review. Pain Ther. 2017 61 6, 25–33. https://doi.org/10.1007/S40122-017-0091-4
  9. Grothe, D.R., Scheckner, B., Albano, D., 2004. Treatment of Pain Syndromes with Venlafaxine. Pharmacother. J. Hum. Pharmacol. Drug Ther. 24, 621–629. https://doi.org/10.1592/PHCO.24.6.621.34748
  10. Gültekin, H., Ahmedov, V., 2006. The Roles of the Opioidergic System a